The Hereditary Angioedema Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Hereditary Angioedema Therapeutics Market?
The hereditary angioedema therapeutics market has experienced rapid growth, expanding from $6.68 billion in 2024 to a projected $7.84 billion in 2025. This represents a compound annual growth rate (CAGR) of 17.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Hereditary Angioedema Therapeutics Industry?
The Hereditary Angioedema Therapeutics Global Market is projected to reach a market value of $16.11 billion in 2029, growing at a compound annual growth rate (CAGR) of 19.7%.
Download Your Free Sample of the 2025 Hereditary Angioedema Therapeutics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Hereditary Angioedema Therapeutics Market?
The key drivers in the hereditary angioedema therapeutics market are:
• Advancements in targeted therapies for hereditary angioedema
• Expansion of the global market in this sector
• Developments in gene therapy for treating hereditary angioedema
• Increased collaboration in research and treatment of the condition
Global Market Segmentation: Identifying Major Hereditary Angioedema Therapeutics Industry Segments
The hereditary angioedema therapeutics market covered in this report is segmented –
1) By Drug Class: C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Other Drug Classes
2) By Route of Administration: Intravenous, Subcutaneous, Oral
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
4) By Application: Prophylaxis, On-demand
Pre-order the 2025 Hereditary Angioedema Therapeutics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Hereditary Angioedema Therapeutics Market?
The key trends in the hereditary angioedema therapeutics market are:
• Advancements in targeted therapies will shape the future of the market.
• The increasing trends of gene therapy and personalized medicine are expected to influence the market.
• Global access initiatives and health economic outcomes research are emerging trends.
• Early intervention strategies and the development of pediatric therapeutics for HAE are on the rise.
Who Are the Top Competitors & Leading Players in the Hereditary Angioedema Therapeutics Market?
The major players in the hereditary angioedema therapeutics market are:
• Sanofi S.A
Regional Dominance: Which Area Leads the Global Hereditary Angioedema Therapeutics Market?
North America was the largest region in the global hereditary angioedema therapeutics market in 2024
